30 Prime-supported Medicare contracts earn quality bonuses

92% of Prime-supported Medicare Advantage members will be in contracts that earned a quality bonus payment from CMS

November 16, 2021

Prime Therapeutics (Prime) helped 30 of its Medicare Advantage Prescription Drug (MAPD) contracts, representing 92% of MAPD membership, receive a quality bonus payment for earning four stars or more in the ratings released by the Centers for Medicare and Medicaid Services (CMS). This includes five contracts that achieved a 5-Star overall rating, and 10 new contracts that earned a quality bonus payment compared to last year.

Stars and total drug management

As a pharmacy benefit manager, Prime influences many of the Star rating measures across:

  • Operations
  • Customer experience
  • Medication adherence and clinical management

Prime helped improve our plans’ ratings for Consumer Assessment of Healthcare Providers and Systems (CAHPS) surveys, which are highly weighted measures in determining overall ratings. These member surveys include an overall rating of the drug plan, and how easy it is for the member to get needed prescriptions.

“These ratings show that Prime is contributing to improving the quality of health care, while at the same time making health care more affordable and accessible to Medicare members,” says Kim Kishel-Geiger, senior director, quality management. “Each year favorable ratings become more difficult to achieve because the bar is continually raised, so we must continue to be innovative.”

Related news

Stories

May 25, 2022

Three Minutes with Kelly Pokuta

Dr. Kelly Pokuta is vice president, trade relations & strategy and chief trade…

Stories

May 23, 2022

Biosimilar use alone won’t cut drug costs

We see it time after time. High-potential innovation that just doesn’t seem to…

Stories

May 13, 2022

Prime expert showcases medical specialty drug management solutions

Prime Therapeutics’ (Prime) Chris Ford, assistant vice president, strategy and innovation, was a…